Biologic Drugs With Established Pharmaceutical Class: Complement Inhibitor
✉ Email this page to a colleague
Biologic Drugs With Established Pharmaceutical Class: Complement Inhibitor
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Alexion Pharmaceuticals, Inc. | SOLIRIS | eculizumab | Injection | 125166 | 2007-03-16 | ⤷ Sign Up | ⤷ Sign Up |
Alexion Pharmaceuticals, Inc. | SOLIRIS | eculizumab | Injection | 125166 | 2007-03-16 | ⤷ Sign Up | ⤷ Sign Up |
Alexion Pharmaceuticals, Inc. | SOLIRIS | eculizumab | Injection | 125166 | 2007-03-16 | ⤷ Sign Up | ⤷ Sign Up |
Alexion Pharmaceuticals, Inc. | SOLIRIS | eculizumab | Injection | 125166 | 2007-03-16 | ⤷ Sign Up | ⤷ Sign Up |
Alexion Pharmaceuticals, Inc. | ULTOMIRIS | ravulizumab-cwvz | Injection | 761108 | 2018-12-21 | ⤷ Sign Up | ⤷ Sign Up |
Alexion Pharmaceuticals, Inc. | ULTOMIRIS | ravulizumab-cwvz | Injection | 761108 | 2018-12-21 | ⤷ Sign Up | ⤷ Sign Up |
Alexion Pharmaceuticals, Inc. | ULTOMIRIS | ravulizumab-cwvz | Injection | 761108 | 2018-12-21 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |